While rejoicing over the reunions, the families underscored that their mission is far from over: more than 90 hostages remain in Gaza.
| | | Families of Freed Hostages Open Up About Their Feelings | | Families of four young Israeli women freed from Hamas captivity Karina Ariev, Daniella Gilboa, Naama Levy, and Liri Albag shared their relief and gratitude in a heartfelt meeting with reporters at Beilinson Hospital in Petah Tikva. While rejoicing over the reunions, the families underscored that their mission is far from over: more than 90 hostages remain in Gaza. | |
|
|
|
| | Netanyahu Plans Washington Visit to Meet Trump | | Prime Minister Benjamin Netanyahu is preparing for a significant visit to Washington next week, where he is expected to meet U.S. President Donald Trump. If finalized, the meeting would mark Netanyahu as the first foreign leader to visit Trump during his second term in office. The visit, tentatively scheduled from Sunday to Wednesday, depends on Netanyahu’s recovery from recent prostate surgery. | |
|
|
|
| Did You Know? “Judea and Samaria, historically known as the biblical heartland of Israel, have been central to Jewish history for over 3,000 years. These regions were home to ancient Israelite tribes, the Kingdom of Judah, and key biblical cities like Hebron, Shiloh, and Shechem. The Jewish connection to this land dates back to Abraham, who purchased the Cave of the Patriarchs in Hebron, and to King David, who ruled from Hebron before establishing Jerusalem as his capital. Despite conquests and exiles, Jewish life in Judea and Samaria persisted for millennia, reaffirming their deep-rooted connection to the land." |
|
|
|
| Israeli Female Astronaut Joins NASA Mission to Space | | Israel is preparing to make history by sending its first female astronaut into space, thanks to a groundbreaking agreement with NASA. Minister of Innovation, Science, and Technology Gila Gamliel shared the exciting news at the 20th Ilan Ramon International Space Conference in Tel Aviv, emphasizing Israel's growing prominence in the global space industry. | |
|
| |
|
| | FDA Approves Fast Track for Israeli Breakthrough in Artery Disease Treatment | | The U.S. Food and Drug Administration (FDA) has granted Fast Track approval to an Israeli-developed treatment that could transform the lives of patients suffering from severe artery disease. Created by BioGenCell, the groundbreaking therapy, BGC101, targets Critical Limb-Threatening Ischemia (CLTI), a dangerous microvascular disease that often leads to amputation and high mortality rates. | |
|
|
|
| |
| | You received this email because you subscribed to our list or a list we sponsor by signing a petition, joining a newsletter, entering a giveaway/contest, or participating in other similar activities. Our company never sends unsolicited emails. If you wish to opt out, please click the link at the bottom of this email at any time. | This email may contain links to third-party advertisers. We assume no responsibility for the content of these sites or the availability, nature, or safety of the advertised products or services. The inclusion of links does not constitute an endorsement or a recommendation of the content they contain. We may have an affiliate relationship and/or other material connection to businesses mentioned or linked to in this email. We may receive a commission on purchases or sign-ups on the following websites. Therefore, do not evaluate products or services based solely on the information provided in this email. Always exercise due diligence before purchasing any product or service. In no event will we be liable for any loss or damage, including without limitation, indirect or consequential loss or damage, or any loss or damage whatsoever arising from loss of data or money arising out of, or in connection with, the use of the websites to which links may lead from this email. | We are strongly committed to protecting your privacy and providing a safe online experience for all of our visitors while offering a high-quality user experience. We know that you care about how the information you provide to us is used and shared. Therefore, we have created a Privacy Policy to inform you of our policies regarding the collection, use, and disclosure of information we receive from our users, which can be found in the footer of our website. | |
| Update your email preferences or unsubscribe here © 2025 Israfan 228 Park Ave S, #29976, New York, New York 10003, United States | | Terms of Service |
|
|
|
|
|
